Search PubMed⌕ Search

Biomedical subjects

A Maggio

Publications and source records attributed to A Maggio.

83 records · Page 5Linked to original sources
PubMedDate not supplied

A region upstream of the human delta-globin gene shows a stage-specific interaction with globin promoters in erythroid cell lines.

We previously showed that the 651-bp DNA fragment, located 3 kb upstream from the human delta-globin gene (fragment F5), is able to inhibit adult, not fetal, globin promoter in mouse erythroleukemia cell lines (MEL) expressing adult globin genes. Here we show in transient analysis that fragment F5 has a strong inhibitory effect on fetal gamma-globin promoter in human erythroleukemia cell lines (HEL) expressing fetal globin genes. Since the beta-promoter constructs were poorly expressed in fetal cells, new plasmids containing an HPFH promoter (Ggamma(-175), T to C), which is strongly expressed in both fetal and adult cell lines, were made. Here we report that fragment F5 in HEL cells has a strong inhibitory effect on wild-type gamma-promoter only; no effect was evident on gamma(-175)-promoter in either MEL or HEL cell lines. Altogether these results show a stage-specific interaction between fragment F5 and globin promoters during development. We also report the presence of several bindings for erythroid GATA family factors by electrophoretic mobility shift assay, using nuclear extracts from erythroid cell lines.

Animals↗
PubMedDate not supplied

Titanium: a promising new material for food contact. A study of titanium resistance to some aggressive food simulants.

It is well known that titanium is one of the most rugged metals; therefore it has been extensively used in many critical fields. However, the lowering of price and an increased availability of titanium has made this material suitable to be used in other industrial fields, such as the food industry. The present paper reports the results of an assessment that concludes that titanium could be regarded as a candidate food-grade material.

Food Contamination↗
PubMedDate not supplied

[The liver in patients with beta-thalassemia major. Determination of iron levels with magnetic resonance].

INTRODUCTION: We investigated the clinical usefulness of liver MRI in a large multicenter study because the control of iron concentration (LIC) is crucial in thalassemia major (TM) prognosis and conflicting results have been reported in small and heterogeneous groups of patients using Magnetic Resonance Imaging (MRI), the only very common non-invasive procedure. MATERIAL AND METHODS: One hundred and eight consecutive TM patients, selected according to a specific protocol, were included in the study. In 29 of these LIC was measured by atomic absorption spectrophotometry on liver biopsy and expressed as microgram/gr dry weight. MRI was performed with a 0.5 T superconducting unit. The ratio of the average signal intensity (SIR) of the liver to that of paraspinal muscle was calculated and expressed as a percentage. RESULTS: Mean +/- (SD) of SIR was 100 +/- 26% (test for normality: p = 0.02) and of LIC was 3677 +/- 4662 micrograms/g/dry liver (test for normality: p < 0.00001). The logit transformation of LIC (lLIC) achieved both normality of distribution of lLIC and linear regression of lLIC on SIR (t = 7.36; p < 0.00001) according to the equation: Y = -0.0136 + SIR* (0.157) = lLIC log10 (K-LIC/LIC) where K = 79.433. Thus the values of LIC are expressed by the equation LIC K/(1 + 10 y) micrograms/g/dry liver. Moreover, a mild correlation was found between SIR and AST (p = 0.01; r = -0.30), ALT (p = 0.02; r = -0.21), gamma GT (p = < 0.01; r = -0.37; r = -0.25). CONCLUSIONS: This study shows that LIC can be calculated as a function of SIR. A validation study is necessary before introducing this prediction rule in clinical practice.

Adult↗
PubMedDate not supplied

alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.

BACKGROUND: Chronic infection with the hepatitis C virus (HCV) and iron overload are the main causes of chronic liver disease in subjects with homozygous beta-thalassemia (HBT). Iron overload can be counteracted by intensive chelation. alpha-interferon reduces viremia and necroinflammation in patients with chronic HCV hepatitis. METHODS: To assess the effectiveness and safety of alpha 2b-Interferon (IFN), we enrolled in an open pilot trial of treatment 12 patients with HBT and biopsy-proven anti-HCV positive chronic hepatitis. IFN was given at a dose of 5 MU/m2 thrice weekly for 8 weeks, then 3 MU/m2 thrice weekly for 18 weeks. Patients were followed up to 24 months after stopping treatment when a second liver biopsy was performed in subjects with sustained response (normal ALT during follow-up). RESULTS: Two patients discontinued IFN at 7 weeks because of haemolytic anemia and one after 8 weeks due to persistent fever. Among 9 subjects completing the protocol, 5 normalized ALT while on treatment and a further 2 within two months after stopping IFN. A sustained response was obtained altogether in 5 patients, since ALT relapsed in 2 responders. None of the 3 subjects who discontinued IFN and of the 2 patients who did not respond to treatment normalized ALT over a 24 months follow-up. Post-treatment liver histology in long-term responders showed a reduction of portal, periportal and lobular necroinflammation, while siderosis was essentially unchanged. CONCLUSIONS: Although the pattern of response to IFN in HCV-infected subjects with HBT might differ from that of non-thalassemics, due to peculiar side effects and delayed response, the drug appears to be effective and deserves further investigation.

Adolescent↗
PubMedDate not supplied

Delta + 27 homozygosis in a Sicilian family.

During a screening program to identify at risk couples for beta-thalassemia first-trimester prenatal diagnosis, we were able to detect, by polymerase chain reaction (PCR) and direct genomic sequencing of the PCR product, a homozygosis for the G-T substitution at the first nucleotide of codon 27 of the delta-globin gene in a pregnant Sicilian woman. The possibility of showing an interaction between delta and beta thalassemia is relevant for a thalassemia prevention program because it may hide a beta-thal carrier state.

Base Sequence↗
PubMedDate not supplied

First trimester fetal blood sampling.

The authors report 8 diagnostic cordocentesis performed at the end of the first trimester. The indication was thalassemia (5 cases) and karyotyping (3 cases). The technique requires that the operator holds both the probe and the needle (25 G X 90 mm); the fetal blood sample ranged between 0.25 and 0.35 cc, sufficient in all cases for the diagnosis. 1 pregnancy was terminated on the basis of the diagnostic result; no complications reported at a 3-weeks follow-up in the remaining 7 patients. The first trimester cordocentesis offers several advantages if compared to CVS, especially for thalassemia prenatal diagnosis; furthermore it opens new perspectives for intrauterine transplantations. More experience is required to assess the safety of the procedure.

Blood Specimen Collection↗
PubMedDate not supplied

Clinical results and fetal biochemical data in 140 early second trimester diagnostic cordocenteses.

The authors report their experience on 140 diagnostic cordocenteses performed in the early trimester of pregnancy (technique, indications and complications). Furthermore the Authors report preliminary data concerning various fetal blood biochemical parameters (22) obtained by cordocentesis at 18-19 weeks of pregnancy (42 cases). Fetal and maternal values are compared.

Female↗